Sutton Wealth Advisors’s Acorda Therapeutics ACOR Stock Holding History

Sutton Wealth Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21	Closed	-$7.13K	–	1210
2019 Q3	$7.13K	Buy	21 +11	+110%	+$5.98K	﹤0.01%	868
2019 Q2	$9.1K	Buy	10 +5	+100%	+$6.14K	0.01%	796
2019 Q1	$7.2K	Sell	5 -1	-17%	-$1.8K	﹤0.01%	863
2018 Q4	$11.1K	Buy	6 +1	+20%	+$2.18K	0.01%	711
2018 Q3	$10.7K	Hold	5	–	–	0.01%	773
2018 Q2	$15.6K	Hold	5	–	–	0.01%	691
2018 Q1	$12.8K	Hold	5	–	–	0.01%	739
2017 Q4	$11.6K	Hold	5	–	–	0.01%	732
2017 Q3	$12.8K	Hold	5	–	–	0.01%	700
2017 Q2	$10.7K	Hold	5	–	–	0.01%	734
2017 Q1	$13K	Hold	5	–	–	0.01%	645
2016 Q4	$11.6K	Buy	5 +1	+25%	+$2.38K	0.01%	652
2016 Q3	$10.7K	Buy	+4	New	+$11.9K	0.01%	644

Other funds holding ACOR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sutton Wealth Advisors's ACOR Position: Q4 2019 in Review

Sutton Wealth Advisors sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 21 shares — an estimated $7.13K sold.

Sutton Wealth Advisors first reported a position in ACOR in Q3 2016 and held it in 13 quarters. The position peaked at $15.6K in Q2 2018. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

Sutton Wealth Advisors reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
Sutton Wealth Advisors sold 21 Acorda Therapeutics shares in Q4 2019, an estimated $7.13K.
Sutton Wealth Advisors first reported a position in Acorda Therapeutics in Q3 2016 and held it in 13 quarters.
Sutton Wealth Advisors's Acorda Therapeutics position peaked at $15.6K in Q2 2018.
121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Sutton Wealth Advisors's 13F filing for Q4 2019, filed 7 Nov 2023.